🔎 Trials Near Me

Akèy › Maladi Parkinson › Kansas › Kansas City

Etid klinik pou Maladi Parkinson nan Kansas City, KS

8 etid pou Maladi Parkinson ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Ap rekriteFaz 2
  • University of Kansas Medical Center, Kansas City
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Ap rekriteFaz 2/3
  • Site-029, Kansas City
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268

A Study of Buntanetap in Participants With PD

Ap rekriteFaz 2/3
  • University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Ap rekriteFaz 2
  • The University of Kansas (KU) (Site #216), Kansas City
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Ap rekriteFaz 3
  • University of Kansas Medical Center, Kansas City
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Ap rekriteFaz 3
  • University of Kansas Medical Center, Kansas City
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Kansas Medical Center, Kansas City
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Ap rekriteFaz 4
  • University of Kansas Medical Center, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668

Etid Maladi Parkinson nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.